Solid Biosciences Inc
Company Overview
Solid Biosciences Inc. is a biotechnology company focused on developing genetic medicines to improve the lives of patients with devastating diseases. The company's lead product candidate, SGT-001, is designed to treat Duchenne muscular dystrophy (DMD), a rare genetic disease characterized by progressive muscle degeneration and weakness.
The company operates primarily in research and development, working to advance its gene therapy programs through clinical trials. They are currently in pre-revenue stage, focusing on developing treatments for serious diseases with significant unmet medical needs.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Solid Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.